Biotech Specialty Pharma

Immune Pharmaceuticals

1120 avenue of the Americas 14th Floor
New York, NY 10036 USA
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Develops drugs to fight Neurodegenerative diseases and cancer.

Management Marc Rotherberg, Chief Scientific Officer; Suzy Jones, Chief Business Development Officer; Serge Goldner, Chief Financial Officer; Jean Kadouche, VP

Click here for Financial Data
Keywords: inflammatory disease, ulcerative colitis, colitis, asthma, monoclonal antibodies, opthalmology, AMD, dermatology, oncology, cancer


Updated: Oct. 22, 2015


IMMUNE Pharmaceuticals is a privately held Israeli company, and EpiCept Corporation (EpiCept) (NASDAQ OMX Stockholm Exchange and OTCQX: EPCT) have entered into a definitive merger agreemen......view more


IMMUNE is rapidly developing its lead programs, starting Phase 2 human clinical trial for its lead product candidate Bertilimumab in 2012 and 2013. The first Phase 2 clinical study of Bertilimumab is ...view more